Clinical Trial Update: A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases [Phase 1]

View source ↗

Summary

Phase 1 study of Anitocabtagene Autoleucel for non-oncology plasma cell-related diseases is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Anitocabtagene Autoleucel (anitocabtagene autoleucel)

Snippet

Sponsor: Arcellx, Inc. | Conditions: Muscular Diseases, Neuromuscular Manifestations | Phase 1 | Status: RECRUITING